barcelona . spain - European Association for the Study of the Liver

BARCELONA . SPAIN
110 POSTGRADUATE COURSE SYLLABUS ALCOHOLIC LIVER DISEASE 111
APRIL 18 - 19/2012 THE INTERNATIONAL LIVER CONGRESS TM 2012
Gassul MA, Short- and long-term outcome of severe alcohol-induced hepatitis treated with
steroids or enteral nutrition: a multicenter randomized trial. Hepatology, 2000. 32: p. 36-42.
Hart, C.L., et al., Effect of body mass index and alcohol consumption on liver disease:
analysis of data from two prospective cohort studies. BMJ, 2010. 340: p. c1240.
Mendenhall CL, A.S., Garcia-Pont P, Goldberg S, Kiernan T, Seef LB, Sorrell M,
Tamburro C, Weesner R, Zetterman R, Chedid A, Chen T, Rabin L, Short-term and
long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone.
N Engl J Med, 1984. 311: p. 1464-1470.
Mathurin P, O.G.J., Carithers RL, Phillips M, Louvet A, Mendenhall CL, Ramond MJ,
Naveau S, Maddrey WC, Morgan TR, Corticosteroids improve short-term survival in patients
with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut, 2011. 60: p. 255-260.
Daures JP, P.P., Bories P, Blanc P, Youfsi A, Michel H, Gremy F., Place de la corticothérapie
dans le traitement des hépatites alcooliques aiguës. Résultats d’une méta-analyse.
Gastroenterol Clin Biol, 1991. 15: p. 223-8.
Imperiale TF, M.A., Do corticosteroids reduce mortality from alcoholic hepatitis
Ann Intern Med, 1990. 113: p. 299-307.
Reynolds TB, Corticosteroid therapy of alcoholic hepatitis: how many studies it will take
Hepatology, 1990. 12: p. 619-621.
Imperiale TF, O.C.J., McCullough AJ, Corticosteroids are effective in patients with severe
alcoholic patients. Am J Gastroenterol, 1999. 94: p. 3066-3067.
Akriviadis E, B.R., Briggs W, Han S, Reynolds T, Shakil O, Pentoxifylline improves
short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled
trial. Gastroenterology, 2000. 119: p. 1637-1648.
Lebrec D, T.D., Oberti F, Perarnau JM, Condat B, Barraud H, Saliba F, Carbonell N,
Renard P, Ramond MJ, Moreau , Poynard T, Pentoxifylline does not decrease short-term
mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology,
2010. 138(5): p. 1755-1762.
Krishna De B, G.S., Dutta D, Baksi SD, Pani A, Ghosh P, Pentoxifylline versus prednisolone
for severe alcoholic hepatitis: a randomized controlled trial. World J Gastroenterol, 2009. 15(13):
p. 1613-1619.
Louvet A, D.E., Dharancy S, Coevoet H, Texier F, Thévenot T, Deltenre P, Canva V,
Plane C, Mathurin P, Early switch to pentoxifylline in patients with severe alcoholic
hepatitis is inefficient in non-responders to corticosteroids J Hepatol 2008. 48: p. 465-470.
Spahr L, R.-B.L., Pugin J, Giostra E, Frossard JL, Borisch B, Hadengue A, Rapid changes
in alcoholic hepatitis histology under steroids: correlation with soluble intercellular
adhesion molecule-1 in hepatic venous blood. J Hepatol, 2001. 35: p. 582-589.
Naveau S, C.-M.S., Dharancy S, Mathurin P, Jouet P, Piquet MA, Davion T, Oberti F, Broët P,
Emilie D, A double blind randomized controlled trial of infliximab associated with prednisolone
in acute alcoholic hepatitis. Hepatology, 2004. 39: p. 1390-1397.
Boetticher NC, P.C., Kwo P, Abrams GA, Patel T, Aqel B, Boardman L, Gores GJ, Harmsen
WS, McClain CJ, Kamath PS, Shah VH, A randomized, double-blinded, placebo-controlled
multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology,
2008. 135(6): p. 1953-60.
Moreno C, L.P., Hittelet A, Lasser L, Degre D, Evrard S, Colle I, Lemmers A, Deviere J,
Le Moine O, Enteral nutrition with or without N-acetylcysteine in the treatment of severe
acute alcoholic hepatitis: a randomized multicenter controlled trial. J Hepatol, 2010. 53(6):
p. 1117-1122.
Nguyen-Khac E, T.T., Piquet MA, Benferhat S, Goria O, Chatelain D, Tramier B,
Dewaele F, Ghrib S, Rudler M, Carbonell N, Tossou H, Bental A, Bernard-Chabert B,
Dupas JL, Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med,
2011. 365(19): p. 1781-1789.
Dew, M.A., et al., Meta-analysis of risk for relapse to substance use after transplantation
of the liver or other solid organs. Liver Transpl, 2008. 14(2): p. 159-72.
Mathurin P, M.C., Samuel D, Dumortier J, Salleron J, Durand F, Castel H, Duhamel A,
Pageaux GP, Leroy V, Dharancy S, Louvet A, Boleslawski E, Lucidi V, Gustot T,
Francoz C, Letoublon C, Castaing D, Belghiti J, Donckier V, Pruvot FR, Duclos-Vallee JC,
Early liver transplantation for severe alcoholic hepatitis. N Engl J Med, 2011. 365(19): p. 1790-800.
Figure 1
Meta-analysis of individual patient data (n=418) from five RCTs comparing corticosteroid treatment with
placebo, enteral nutrition or an antioxidant cocktail. Estimated 28-day survival according to treatment in
(A) complete responders to corticosteroids (Lille score 0.56). From Mathurin P et al. Gut 2011 [25] with permission.